Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation

Completed · Phase 2 · Has a placebo group

Conditions studied: Impaired Dark Adaptation

In brief

This is a Phase IIa proof-of-concept study to evaluate the effects of oral QLT091001 on adults with impaired dark adaptation.

Key facts

Study ID
NCT01999764
Run by
QLT Inc.
People needed
43
Starts
2013-11-01
Expected to finish
2014-07-01
Last updated by the study team
2015-07-14

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.